longevitywatch
← All podcasts

Dave Asprey

hosted by Dave Asprey

We tested 105 claims from Dave Asprey against the research. 6 held up, 20 did not, and the rest are partly true or still too early to judge.

We only test the claims that can be checked, not everything that is said. This is not a ranking.

Dave Asprey · hosts Dave Asprey

American entrepreneur, author and biohacker

Partly
“Combining L-theanine with caffeine in a 2:1 ratio reduces anxiety and improves attention and reaction speed.”
Dave Asprey (American entrepreneur, author and biohacker) · Dave Asprey, October 2026 · watch the episode ↗︎ · stated with confidence
The combination of L-theanine and caffeine is indeed being studied, and for green tea, which contains both compounds, there are indications that attention and mood improve somewhat. However, the specific 2:1 ratio as a requirement for this effect cannot be substantiated on the basis of the available research. For L-theanine alone, several studies show a reduction in mental stress, although this does not work with every type of stressor. The claim goes beyond what the research can currently support, particularly with regard to the precise dosage ratio and the effect on reaction speed.
Partly
“A series of 60 sessions of hyperbaric oxygen therapy improves executive function, attention and processing speed in healthy adults.”
Dave Asprey (American entrepreneur, author and biohacker) · Dave Asprey, October 2026 · watch the episode ↗︎ · stated with confidence
Hyperbaric oxygen therapy shows encouraging signs in older adults regarding brain function, but the studies are small and the protocols vary considerably. The claim goes beyond the evidence on two counts: the studies concern older adults, not healthy adults in general, and the specific combination of executive function, attention and processing speed after exactly 60 sessions cannot be firmly established based on current research. A broad recommendation for this treatment in healthy adults does not yet exist.
Partly
“Transcranial near-infrared photobiomodulation increases cerebral blood flow and stimulates ATP production in the mitochondria of neurons.”
Dave Asprey (American entrepreneur, author and biohacker) · Dave Asprey, October 2026 · watch the episode ↗︎ · stated with confidence
Research in humans does indeed show that transcranial near-infrared photobiomodulation can increase blood flow to the brain. A review of 45 studies, including 19 randomised controlled trials in humans, concludes that tPBM is recommended for improving cerebral blood flow. Smaller studies in humans, both in healthy older women and in people with dementia or brain injury, find comparable effects on blood flow. For ATP production in the mitochondria of brain cells, however, the evidence is based on laboratory and animal research: studies using isolated cell mitochondria and involving fruit flies and mice show that near-infrared light stimulates ATP production, but this has not yet been measured directly in humans. The claim therefore combines an effect that is reasonably well supported in humans with a mechanism of action that has so far only been demonstrated in the laboratory and in animals.
Partly
“Cerebrolysin improves attention, memory and processing speed in patients recovering from a stroke or brain injury.”
Dave Asprey (American entrepreneur, author and biohacker) · Dave Asprey, October 2026 · watch the episode ↗︎ · stated with confidence
Several clinical studies in humans show that cerebrolysin can promote the recovery of cognitive function and daily functioning after a stroke or brain injury. A randomised controlled trial in patients with mild brain injury shows improvements in memory, and a large multicentre study in stroke patients shows improved cognitive scores compared to a control group. The effect appears to be strongest in patients with moderate to severe stroke, while it is less clear in milder cases. The claim is therefore broadly correct for patients with a stroke or brain injury, but is slightly too broad: the studies emphasise that the benefit is most apparent in more severely affected patients and in combination with rehabilitation. In addition, the body of evidence remains limited in terms of study size, and there are indications that some researchers may have had a personal interest in the outcomes.
Partly
“Isolated nicotine in low doses (1–2 mg) improves attention, reaction speed and working memory via nicotinic acetylcholine receptors.”
Dave Asprey (American entrepreneur, author and biohacker) · Dave Asprey, October 2026 · watch the episode ↗︎ · repeated in September 2026 · stated with confidence
Research in both humans and animals does indeed show that nicotine can improve attention, working memory and also episodic memory, and that nicotinic acetylcholine receptors play a central role in this. That much is correct. However, the claim specifically mentions a dose range of 1–2 mg, whereas the studies do not cite this exact range and instead indicate that the effects are highly dependent on dose, duration of exposure and whether or not a person is a smoker. Moreover, several review studies emphasise that high doses and prolonged use can actually be harmful to memory, and that negative effects occur in young people and during the prenatal period. The claim therefore paints a simpler and more positive picture than the research warrants.
✓ Holds up
“Breathing through the nose synchronises electrical brain waves in the hippocampus and amygdala”
Dave Asprey (American entrepreneur and author, known as the founder of Bulletproof Coffee and biohacking) · Dave Asprey, October 2026 · watch the episode ↗︎ · stated with confidence
Several studies, both in humans and in rodents, show that nasal breathing synchronises electrical brain activity in the hippocampus and amygdala with the breathing rhythm. The human evidence comes in part from a study in which brain signals were measured directly in patients with epilepsy, and which shows that this effect disappears as soon as you breathe through the mouth. A recent fMRI study in healthy people confirms that nasal breathing is associated with stronger connectivity in brain networks encompassing the hippocampus and amygdala. The claim captures the core of what the research shows well.
Partly
“A single night without sleep leads in humans to an increase in beta-amyloid of approximately 5 percent in the thalamus and hippocampus”
Dave Asprey (American entrepreneur and author, known as the founder of Bulletproof Coffee and biohacking) · Dave Asprey, October 2026 · watch the episode ↗︎ · stated with confidence
A study in 20 healthy people shows that one night of sleep deprivation leads to a clear increase in beta-amyloid in the right hippocampus and thalamus, two specific brain regions. This was measured using a special brain scan that makes certain substances in the brain visible. The claim is therefore correct regarding the locations and the direction of the effect. However, the stated percentage of "approximately 5 percent" does not appear in the abstract of that study, which means this figure cannot be confirmed or refuted on the basis of this research. Other research in humans measures beta-amyloid differently, namely in blood or cerebrospinal fluid, and shows varying results, which further nuances the precise claim. → What does one bad night of sleep do to your brain?
Partly
“The sleeping pill zolpidem suppresses noradrenaline oscillations and glymphatic flow in mice, causing approximately 30 percent less waste to be cleared”
Dave Asprey (American entrepreneur and author, known as the founder of Bulletproof Coffee and biohacking) · Dave Asprey, October 2026 · watch the episode ↗︎ · stated with confidence
The study in the scientific journal Cell, conducted in mice, does indeed show that zolpidem suppresses fluctuations in noradrenaline and the brain's cleansing activity. The claim is therefore correct regarding the direction and mechanism, and it is also correct that the study involved mice. However, the specific figure of "approximately 30 percent less waste clearance" does not appear in the abstract of that study; this figure cannot be verified on the basis of the available abstracts. The other studies support the broader picture surrounding noradrenaline and the brain's cleansing activity, but likewise do not mention the percentage. → Does a sleeping pill really help your brain clean itself during sleep?
Partly
“During sleep, the space between brain cells increases by about 60 percent, causing the removal of waste products to roughly double.”
Dave Asprey (American entrepreneur and author, known as the founder of Bulletproof Coffee and biohacking) · Dave Asprey, October 2026 · watch the episode ↗︎ · stated with confidence
It is well established that sleep activates a drainage system in the brain that clears harmful proteins. However, the specific figures in the claim, namely the 60 percent increase in intercellular space and the doubling of drainage, cannot be substantiated on the basis of the available research in humans. Large reviews of studies in healthy people have also yielded contradictory results regarding which sleep phase or exactly how many hours make the most difference.
Partly
“Every percentage point of deep sleep lost per year is associated with a 27% higher risk of dementia in people over sixty.”
Dave Asprey (American entrepreneur and author, known as the founder of Bulletproof Coffee and biohacking) · Dave Asprey, October 2026 · watch the episode ↗︎ · repeated in November 2026 · stated with confidence
The direction is correct: research does indeed show that each percentage point of deep sleep lost is associated with a 27% higher risk of dementia, but that figure comes from a single observational study of nearly 350 people. Whether this association is causal has not yet been established, and it is equally uncertain whether the findings can be generalised to all people over sixty. The claim therefore presents an association somewhat more definitively than the research warrants.
✗ Does not hold up
“The proportion of deep sleep falls from around 19% in young adults to just 3.4% in middle-aged adults”
Dave Asprey (American entrepreneur and author, known as the founder of Bulletproof Coffee and biohacking) · Dave Asprey, October 2026 · watch the episode ↗︎ · repeated in November 2026 · stated with confidence
It is well established that the proportion of deep sleep decreases with age, and this decline begins before the age of forty. The specific percentages cited here (around 19% in young adults, falling to 3.4% in middle age) do not appear in the available research, and such precise figures cannot therefore be substantiated. This is not a dispute about the direction of the claim, but the claim presents numbers that are too precise for what the research supports.
Partly
“Creatine boosts ATP production in brain cells and improves cognitive performance during sleep deprivation or stress.”
Dave Asprey (American entrepreneur, author and biohacker, founder of Bulletproof) · Dave Asprey, September 2026 · watch the episode ↗︎ · repeated in October 2026 · stated with confidence
It is true that creatine plays a role in the energy metabolism of brain cells through the ATP system, and there are positive indications that it can relieve cognitive complaints during sleep deprivation. However, the effect has not been broadly proven: it is strongest in people with elevated fatigue, sleep deprivation, or a plant-based diet, and for healthy, well-rested people creatine appears to do little. The claim gives the impression that creatine improves cognition in everyone experiencing sleep deprivation or stress, while the research for this is still too limited and too inconsistent.
Partly
“Standardized ashwagandha extract reduces cortisol levels by approximately 28 percent.”
Dave Asprey (American entrepreneur, author and founder of the biohacking movement) · Dave Asprey, August 2026 · watch the episode ↗︎ · repeated in October 2026 · stated with confidence
Research does indeed show that ashwagandha can measurably lower cortisol levels, but the best available meta-analysis shows no consistent or convincing effect on how stressed people actually feel. The specific figure of 28 percent does not appear in the available research, and results vary across studies, doses, and populations. So while the direction is correct, that precise percentage cannot be substantiated based on the available evidence.
Partly
“A daily intake of 25 to 30 grams of dietary fibre reduces the risk of premature death by 15 to 30 per cent.”
Dave Asprey (American entrepreneur, author and biohacker, founder of Bulletproof) · Dave Asprey, September 2026 · watch the episode ↗︎ · stated with confidence
Our answer on fibre intake confirms that a daily intake of 25 to 29 grams of fibre is associated with a 15 to 30% lower risk of premature death, which supports the direction of the claim. However, the claim differs on one point: the upper limit stated is 30 grams, whereas our answer cites 29 grams as the amount studied. In addition, the research concerns an association, not a proven causal effect, so the phrasing 'reduces total mortality' is more definitive than the evidence allows.
Partly
“Exposure to bright natural daylight during the day reduces the risk of dying from cardiovascular disease and metabolic conditions.”
Dave Asprey (American entrepreneur, author and biohacker, founder of Bulletproof) · Dave Asprey, September 2026 · watch the episode ↗︎ · stated with confidence
There is plausible evidence that too little sunlight is associated with a higher risk of cardiovascular disease, but a proven causal relationship has yet to be established. The claim that exposure to bright daylight reduces the risk of dying from cardiovascular disease and metabolic disorders goes beyond what research can currently support. Moreover, the available evidence focuses on the harmful effects of too little sunlight, not specifically on 'bright' daylight or on mortality from metabolic disorders. The direction is plausible, but the claim is more definitive than the evidence warrants.
Partly
“A glycine and NAC (GlyNAC) supplement restores glutathione levels and reduces oxidative stress in older adults to levels seen in young people.”
Dave Asprey (American entrepreneur, author and biohacker, founder of Bulletproof) · Dave Asprey, September 2026 · watch the episode ↗︎ · stated with confidence
The only controlled human study shows that GlyNAC does indeed have positive effects on glutathione levels and oxidative stress. However, the claim goes beyond the evidence by stating that those levels are restored 'to the levels of young people', given that the study included only 24 participants over 16 weeks. That is too small and too short to justify such a far-reaching conclusion. The direction is correct, but the claim is more definitive than the available research supports.
Partly
“Four to seven sauna sessions a week reduce the risk of sudden cardiac death by 63% and the risk of dying from any cause by 40%.”
Dave Asprey (American entrepreneur, author and founder of the biohacking movement) · Dave Asprey, August 2026 · watch the episode ↗︎ · stated with confidence
Research shows that four or more sauna sessions per week are associated with greater health benefits, including a lower risk of cardiovascular disease and premature death, and that this association is dose-dependent. However, the specific percentages in the claim (63 percent reduction in sudden cardiac death and 40 percent reduction in overall mortality) do not emerge from the research and therefore cannot be confirmed. Moreover, the research emphasises that it is purely observational and that a causal relationship has not been established. The claim presents the figures as established fact, whereas the reality is more nuanced.
Too early
“Taking 1 gram of omega-3 daily slows epigenetic ageing in people over 70.”
Dave Asprey (American entrepreneur, author and founder of the biohacking movement) · Dave Asprey, August 2026 · watch the episode ↗︎ · stated with confidence
Research shows that there are indications that omega-3 slows biological ageing, but these indications are explicitly preliminary and contradictory. The claim is too categorical: it specifies a dose of 1 gram, targets people over 70, and refers to epigenetic ageing, while the available evidence does not support that level of detail. The direction cannot be ruled out, but the certainty and specificity of the claim go beyond what the available evidence allows.
Partly
“Berberine effectively lowers blood sugar levels in humans.”
Dave Asprey (American entrepreneur, author and founder of the biohacking movement) · Dave Asprey, August 2026 · watch the episode ↗︎ · stated with confidence
Research shows that berberine measurably lowers blood sugar, which is consistent with the claim. However, the claim suggests that berberine does so effectively and without reservation, whereas the EFSA has been unable to establish a safe intake level due to indications of DNA and liver damage. In addition, berberine has strong interactions with medications, making its use in practice risky. The blood sugar-lowering effect is therefore real, but the word "effectively" creates an overly positive and incomplete picture.
Partly
“Creatine supplementation leads to an increase in lean muscle mass in older adults.”
Dave Asprey (American entrepreneur, author and founder of the biohacking movement) · Dave Asprey, August 2026 · watch the episode ↗︎ · stated with confidence
Multiple studies show that creatine can improve muscle strength and muscle mass in older adults, which supports the direction of the claim. However, the evidence is strongest when creatine is combined with resistance training; without that combination, the effects are less clear. The claim presents an increase in lean muscle mass as an established fact, but that goes somewhat beyond what the research, which is of moderate quality, justifies.
Partly
“During deep sleep, brain cells shrink, causing the interstitial space to increase by 60% to flush out waste products such as beta-amyloid.”
Dave Asprey (American entrepreneur, author and biohacker) · Dave Asprey, August 2026 · watch the episode ↗︎ · stated with confidence
This comes from a real 2013 study that caused a great stir: during sleep, the space between brain cells increased by about 60 percent and waste was flushed out more quickly. However, the research was conducted in mice. In humans, the brain's waste-clearing system has been visualised, but that precise percentage has not been measured.
✓ Holds up
“Sleep regularity is a stronger predictor of lower mortality than total sleep duration.”
Dave Asprey (American entrepreneur, author and biohacker) · Dave Asprey, August 2026 · watch the episode ↗︎ · stated with confidence
This is exactly what the research concludes. In the UK Biobank, with more than three thousand deaths over seven years, the regularity of sleep was a stronger predictor of mortality than the number of hours slept. Going to bed and waking up at the same time every day therefore matters more than the exact duration. It remains observational research.
Partly
“More light in the bedroom is linked to a 53 to 67% higher risk of developing type 2 diabetes.”
Dave Asprey (American entrepreneur, author and biohacker) · Dave Asprey, August 2026 · watch the episode ↗︎ · repeated in August 2026 · stated with confidence
The direction is correct and there is genuine research on this: in a Japanese cohort of seven hundred older adults, people who slept with light in the bedroom developed diabetes nearly four times as often as people who slept in the dark. That is a far larger difference than the 53 to 67 percent mentioned here, so those figures come from somewhere else. Moreover, this is observational research in older adults with nineteen new cases, making it a small study.
Too early
“Cooling the sleep surface early in the night increases deep sleep in men and REM sleep in women.”
Dave Asprey (American entrepreneur, author and biohacker) · Dave Asprey, August 2026 · watch the episode ↗︎ · stated with confidence
The idea that cooling the sleep environment improves sleep is plausible and is being investigated. However, the specific difference between men and women mentioned here, deep sleep in one group and REM sleep in the other, is not something I have been able to find in the literature. Sex differences of this kind require large studies, and those do not exist on this point.
Partly
“Apigenin binds to the benzodiazepine receptor in the GABA system and produces a calming effect without sedation.”
Dave Asprey (American entrepreneur, author and biohacker) · Dave Asprey, August 2026 · watch the episode ↗︎ · stated with confidence
It has been demonstrated that apigenin acts on the site in the GABA system where sleep medications also work, but this has been shown in test-tube and animal studies. 'Calming without sedation' is a marketing phrase: the dose at which it calms without causing drowsiness has not been established in humans, and the amounts used in those studies are far higher than what you can get from chamomile.
✗ Does not hold up
“Around the age of 45, most men have almost completely lost the ability to generate deep sleep.”
Dave Asprey (American entrepreneur, author and biohacker) · Dave Asprey, August 2026 · watch the episode ↗︎ · stated with confidence
Deep sleep does decrease with age, that is true, and more so in men than in women. But 'almost completely lost' by the age of 45 is not what measurements show: in sleep research, middle-aged men still have perfectly normal deep sleep, just less than they had in their twenties. The decline is gradual and there is no age at which it suddenly tips over.
Partly
“Rhodiola rosea lowers cortisol and improves mental performance under stress.”
Dave Asprey (American entrepreneur, author and biohacker) · Dave Asprey, August 2026 · watch the episode ↗︎ · stated with confidence
There are small studies in which participants felt less fatigued, particularly during prolonged stress. However, the research is poorly designed, the effects on cortisol have not been found consistently, and most of the work comes from manufacturers. As an herb with a possible effect it is interesting, but presenting it as established fact goes too far.
Partly
“Modafinil increases the release of noradrenaline and dopamine in the prefrontal cortex and supports focus for 8 to 12 hours.”
Dave Asprey (American entrepreneur, author and biohacker) · Dave Asprey, August 2026 · watch the episode ↗︎ · stated with confidence
The description of how it works is broadly correct: modafinil inhibits the reuptake of dopamine and lasts roughly as long as a working day. But this is a prescription drug for narcolepsy, not a focus aid. It causes headaches, insomnia, and palpitations, interacts with hormonal contraceptives, and in the Netherlands it cannot legally be obtained without a prescription.
✗ Does not hold up
“A ratio of 2 parts L-theanine to 1 part caffeine is the optimal ratio for focus.”
Dave Asprey (American entrepreneur, author and biohacker) · Dave Asprey, August 2026 · watch the episode ↗︎ · stated with confidence
There is no optimal ratio, because none has ever been studied. The studies used a range of different doses and not one of them compared ratios against each other. Two to one is a number that stuck in the supplement world, not a research finding.
✓ Holds up
“The combination of L-theanine and caffeine improves cognitive performance, working memory and accuracy more than caffeine alone.”
Dave Asprey (American entrepreneur, author and biohacker) · Dave Asprey, August 2026 · watch the episode ↗︎ · stated with confidence
This is one of the few combinations from the nootropics world that actually holds up in randomised research. Theanine combined with caffeine improves task-switching and accuracy more than caffeine alone, largely because it takes the edge off the restlessness caffeine causes. The effects are small, though, and were measured in brief tests rather than across a working week.
Partly
“L-theanine stimulates alpha waves in the brain and reduces cortisol and feelings of anxiety.”
Dave Asprey (American entrepreneur, author and biohacker) · Dave Asprey, August 2026 · watch the episode ↗︎ · repeated in October 2026 · stated with confidence
The alpha waves are accurate: this has been observed in multiple EEG measurements and is the clearest effect of theanine. The rest is weaker. The evidence for reduced anxiety is modest and comes from short-term studies, and the claim that it lowers your cortisol has not been confirmed in the best-quality studies.
Partly
“500 mg to 2 grams of L-tyrosine boosts the production of dopamine and noradrenaline in the brain.”
Dave Asprey (American entrepreneur, author and biohacker) · Dave Asprey, August 2026 · watch the episode ↗︎ · stated with confidence
Tyrosine is indeed the building block your body uses to make dopamine and noradrenaline, and taking it demonstrably raises the levels of these substances in your blood. However, this only leads to increased production in the brain when your reserves are actually depleted, for example after sleep deprivation, exposure to cold, or prolonged stress. In someone who is well-rested, nothing happens.
Partly
“Five minutes of brisk walking before a focus session stimulates the production of focus-enhancing neurotransmitters.”
Dave Asprey (American entrepreneur, author and biohacker) · Dave Asprey, August 2026 · watch the episode ↗︎ · stated with confidence
Brief, vigorous exercise just before mental work measurably improves your attention; that has been observed in multiple studies. What exactly happens in your brain is less clear: the assumption that more neurotransmitters are produced is derived from animal studies and has not been measured in humans.
Partly
“Losing 60 to 90 minutes of sleep disrupts the neurochemical balance of dopamine and noradrenaline needed for focus.”
Dave Asprey (American entrepreneur, author and biohacker) · Dave Asprey, August 2026 · watch the episode ↗︎ · stated with confidence
That sleep deprivation seriously impairs concentration is well established and is one of the most consistently measured effects in sleep science. The accompanying explanation, however, is an oversimplification: it involves far more than two neurotransmitters, and the threshold of 60 to 90 minutes is a round number without any research to back it up. Moreover, every person responds differently to the same degree of sleep loss.

Josh Duhamel

American actor and co-founder of telehealth company Gatlin Health

✗ Does not hold up
“Modafinil raises IQ according to scientific studies.”
Josh Duhamel (American actor and co-founder of telehealth company Gatlin Health) · Dave Asprey, September 2026 · watch the episode ↗︎ · stated with confidence
Research in healthy people shows that modafinil produces at most modest improvements on specific aspects of cognitive performance, such as working memory and attention, but it does not raise IQ. A large meta-analysis finds only a small overall effect on memory processing, another carefully designed study finds no clearly measurable effect of modafinil at all, and one study actually concludes that modafinil does not improve the overall cognitive performance of healthy students. IQ as a measure is not used as an outcome in the research; one study even examined whether a person's existing IQ influences the effects of modafinil, but this is something entirely different from raising IQ.
✗ Does not hold up
“The smell of babies alone lowers testosterone levels in men.”
Josh Duhamel (American actor and co-founder of telehealth company Gatlin Health) · Dave Asprey, September 2026 · watch the episode ↗︎ · stated with confidence
The claim is about humans, but research into the smell of babies and testosterone has been conducted almost entirely in common marmosets, not in humans. In those monkeys, testosterone does indeed drop after exposure to the scent of their own offspring, but only in fathers who already had experience with paternal care. In humans, this effect was tested in men and not found: exposure to the scent had no effect on testosterone levels. The same study did show that the scent of a woman shortly after giving birth increased men's interest in infant faces, but that is something different from a drop in testosterone.
✗ Does not hold up
“Genetically engineered probiotics can neutralise up to 80% of the ageing damage caused by alcohol.”
Josh Duhamel (American actor and co-founder of telehealth company Gatlin Health) · Dave Asprey, September 2026 · watch the episode ↗︎ · stated with confidence
The claim that genetically engineered probiotics can neutralise a large proportion of the ageing damage caused by alcohol is not supported by the research. What we do know is that alcohol causes harm through multiple pathways, including DNA damage, inflammation and liver damage, and that drinking less is the only proven way to limit that harm. Probiotics show modest positive effects on a few markers in older adults, but there is no evidence for genetically engineered variants in humans: the only registered trial in that area was discontinued without results. A figure such as 80% neutralisation has not been demonstrated.
Partly
“Low doses of GLP-1 agonists promote a longer lifespan and may protect against Alzheimer's disease.”
Josh Duhamel (American actor and co-founder of telehealth company Gatlin Health) · Dave Asprey, September 2026 · watch the episode ↗︎ · repeated in November 2026 · stated with caution
For people with existing cardiovascular disease or kidney problems, GLP-1 medications are well supported by evidence, but the claim that they promote a longer lifespan and protect against Alzheimer's is not yet backed up conclusively. The signals regarding brain protection and the prevention of dementia are promising, but have not been confirmed in randomised trials. The claim presents something as an established fact, while research in healthy individuals on this point is not yet complete. Moreover, the available research says little specifically about low doses as a distinct category.
✗ Does not hold up
“Testosterone therapy at the right dosages reduces the risk of death from all causes in both men and women.”
Josh Duhamel (American actor and co-founder of telehealth company Gatlin Health) · Dave Asprey, September 2026 · watch the episode ↗︎ · repeated in November 2026 · stated with confidence
Testosterone therapy has been studied for specific outcomes in people with an established deficiency, and the results are mixed: there is evidence of benefits in terms of body composition, libido and mood, but also real risks of atrial fibrillation, pulmonary embolism and kidney failure. A broader protective effect on all-cause mortality, in both men and women, has not been demonstrated in the available studies. The claim therefore goes considerably further than what the research has shown so far.

Carolina Reis de Oliveira

Co-founder and CEO of OneSkin, PhD in stem cell biology and tissue engineering

Partly
“Wearing a damp face mask for too long (such as all night) causes corneocytes to swell excessively and break down, which actually disrupts the skin barrier.”
Carolina Reis de Oliveira (Co-founder and CEO of OneSkin, PhD in stem cell biology and tissue engineering) · Dave Asprey, September 2026 · watch the episode ↗︎ · stated with confidence
Research in humans does indeed show that wearing a face mask or an airtight bandage for extended periods can damage the skin barrier. A clinical study involving 21 women who wore a mask for at least six hours a day found that the skin lost more moisture and the outermost layer of skin was weakened. A 1999 study also shows that prolonged occlusion can damage the skin barrier, even when the skin does not feel dry. The claim is therefore correct in its general principle that prolonged moist occlusion disrupts the skin barrier. However, the specific mechanism of 'excessive swelling and breakdown of skin cells' is not described or measured in that way in these studies. Moreover, the studies concern daily use over several hours, and not specifically wearing a mask throughout the night.
Partly
“Taking oral collagen provides amino acids that act as signalling molecules to stimulate the body's own collagen production in the skin.”
Carolina Reis de Oliveira (Co-founder and CEO of OneSkin, PhD in stem cell biology and tissue engineering) · Dave Asprey, September 2026 · watch the episode ↗︎ · stated with confidence
The biological mechanism described in the claim is plausible: there are indications that collagen peptides can stimulate skin cells to produce their own collagen. Measurable improvements in skin following intake of hydrolysed collagen have been observed in several studies, but these results come almost exclusively from manufacturer-funded research. The claim presents the mechanism as established fact, whereas independent evidence for it is still lacking. The direction is correct, but the certainty conveyed by the wording goes further than what the research can currently support.
Partly
“Complete collagen molecules are too large to penetrate the skin barrier locally; individual amino acids can do so.”
Carolina Reis de Oliveira (Co-founder and CEO of OneSkin, PhD in stem cell biology and tissue engineering) · Dave Asprey, September 2026 · watch the episode ↗︎ · stated with confidence
Research on mouse skin shows that small collagen breakdown products (fragments of 5 to 13 kDa) can penetrate the skin, whereas complete collagen molecules are considerably larger. This supports the idea that size acts as a threshold. However, the claim points to individual amino acids as the solution, whereas the research shows that it is small peptides (short chains of amino acids) rather than separate amino acids that are involved. Furthermore, the available penetration research concerns mouse skin and laboratory settings, and it has not yet been demonstrated in humans that individual amino acids or small peptides penetrate the skin barrier in sufficient quantities to have any effect.
✗ Does not hold up
“Cells in an early stage of senescence can activate their DNA repair system and become functional again when inflammation in their environment decreases.”
Carolina Reis de Oliveira (Co-founder and CEO of OneSkin, PhD in stem cell biology and tissue engineering) · Dave Asprey, September 2026 · watch the episode ↗︎ · stated with caution
Senescent cells permanently stop dividing and secrete inflammatory substances into their environment. That word "permanently" is essential: current knowledge describes senescence as an irreversible process, not a state that cells can exit once the inflammation in their environment decreases. The claim that early-stage senescent cells can activate their DNA repair system and become functional again when their environment changes goes beyond what research has shown so far.
Partly
“Chronic inflammation caused by the accumulation of senescent cells in an ageing skin barrier can contribute to systemic inflammation in the body.”
Carolina Reis de Oliveira (Co-founder and CEO of OneSkin, PhD in stem cell biology and tissue engineering) · Dave Asprey, September 2026 · watch the episode ↗︎ · stated with confidence
Senescent cells accumulate inflammatory substances and thus form a source of chronic low-grade inflammation; that mechanism is well documented. It is plausible that such local inflammation can also have systemic effects in the body, but the specific route via an ageing skin barrier has not yet been causally demonstrated in humans. The direction of the claim is therefore correct, but the emphasis on the skin as the starting point goes beyond what current research firmly establishes.

Catharine Arnston

Founder and CEO of ENERGYbits and author on algae nutrition

✗ Does not hold up
“Superoxide dismutase converts harmful free radicals in the mitochondrion into oxygen and water.”
Catharine Arnston (Founder and CEO of ENERGYbits and author on algae nutrition) · Dave Asprey, September 2026 · watch the episode ↗︎ · stated with confidence
Superoxide dismutase (SOD) does not convert free radicals into oxygen and water, but into hydrogen peroxide and oxygen. The hydrogen peroxide is then converted into water by other enzymes, such as catalase or glutathione peroxidase. The claim merges two steps and therefore describes an incorrect end product of SOD itself. That your body combats harmful radicals through its own enzymes in the mitochondrion is correct, but the reaction described is not accurate.
Partly
“Chlorella helps remove mercury and heavy metals from the brain.”
Catharine Arnston (Founder and CEO of ENERGYbits and author on algae nutrition) · Dave Asprey, September 2026 · watch the episode ↗︎ · stated with confidence
In mice, two studies show that chlorella increases the excretion of methylmercury via urine and faeces and that mercury levels in both the kidneys and the brain fall markedly. A rat study also shows that chlorella reduces the accumulation of lead in the liver, kidneys and blood, with positive effects on memory as well. There is also one small human study (16 patients) in which a combination of chlorella and other supplements resulted in lower mercury and lead levels in hair, but this did not involve chlorella alone and the brain was not measured. Laboratory research with human cells shows protective effects at the cellular level, but that does not constitute evidence for the removal of metals from the brain in humans. The claim that chlorella specifically helps remove mercury and heavy metals from the brain in humans goes further than what the current evidence shows, which consists largely of research in animals and in the laboratory.
✗ Does not hold up
“Cancer cells cannot survive in an alkaline cellular environment.”
Catharine Arnston (Founder and CEO of ENERGYbits and author on algae nutrition) · Dave Asprey, September 2026 · watch the episode ↗︎ · stated with confidence
Research actually shows the opposite of what the claim states. Cancer cells naturally have an alkaline interior (and an acidic environment outside them), and they thrive in it. That alkaline interior is even a driving force behind the development and spread of cancer. One study shows that a specific agent (JTC801) can kill cancer cells by making the interior of the cell even more alkaline, but this concerns an experimental substance that has only been tested in the laboratory and in mice. It is therefore not evidence that cancer cells simply cannot survive in an alkaline environment. The claim gives the impression that an alkaline environment counteracts cancer, whereas research actually describes an alkaline cell interior as a feature that promotes cancer.
Partly
“Superoxide dismutase (SOD) prevents Alzheimer's disease, cardiovascular disease, and inflammation.”
Catharine Arnston (Founder and CEO of ENERGYbits and author on algae nutrition) · Dave Asprey, September 2026 · watch the episode ↗︎ · stated with confidence
Research shows that SOD plays a role in counteracting damage caused by oxygen radicals in the body, which is involved in inflammatory diseases and cardiovascular diseases. A review study describes protective effects of a specific form of SOD in various inflammatory diseases, and research into administration via special carriers points to possible applications in cardiovascular disease, but this has mainly been studied in laboratory animals and in the laboratory. As for Alzheimer's disease, SOD supplementation helped prevent cognitive decline in mice, but this has not yet been demonstrated in humans. In fact, one study in humans shows that higher SOD activity in the blood is associated with a more severe course of Alzheimer's disease, which makes a straightforward protective effect less obvious. The claim that SOD "prevents" these conditions therefore goes beyond the current evidence, particularly for humans.
✗ Does not hold up
“Improved mitochondrial function reduces the risk of premature death and slows down the ageing process.”
Catharine Arnston (Founder and CEO of ENERGYbits and author on algae nutrition) · Dave Asprey, September 2026 · watch the episode ↗︎ · stated with confidence
Mitochondria play a role in ageing, and there is evidence that mitochondrial mutations contribute to accelerated ageing, but the step to 'improved mitochondrial function reduces overall mortality and slows ageing' has not been demonstrated in humans. Exercise can improve mitochondrial health, but whether that translates into a longer lifespan in humans remains an open question. The claim presents as established fact what research regards, at most, as a plausible mechanism.

Siggy Clavien

Entrepreneur with a background in plant medicine and viticulture, founder of liver health brand Delivrance

Partly
“Stearic acid, a saturated fat found in beef and lamb fat, helps in the recovery from fatty liver disease.”
Siggy Clavien (Entrepreneur with a background in plant medicine and viticulture, founder of liver health brand Delivrance) · Dave Asprey, September 2026 · watch the episode ↗︎ · stated with confidence
Research in mice shows that stearic acid can reduce fatty liver disease via gut bacteria, and one mouse study also shows that stearic acid combined with cell therapy can accelerate the recovery of liver tissue. However, there is also research showing that stearic acid can cause cell death in liver cells, suggesting an opposite effect. In humans, the effect on fatty liver disease has not yet been properly studied: trial registries do list studies involving humans, but published results from those studies are largely absent. The claim that stearic acid helps in the recovery from fatty liver disease therefore goes beyond what the available research in humans currently demonstrates.
Partly
“In about 80% of people with fatty liver disease, standard blood tests show normal values.”
Siggy Clavien (Entrepreneur with a background in plant medicine and viticulture, founder of liver health brand Delivrance) · Dave Asprey, September 2026 · watch the episode ↗︎ · repeated in September 2026 · stated with confidence
Research confirms that fatty liver disease often occurs in people with normal blood values: an editorial in a gastroenterology journal states explicitly that the risk of fatty liver disease remains elevated even when liver enzyme levels fall within the normal range, and multiple guidelines stress that normal enzyme levels certainly do not rule out the condition. However, the specific figure of 80% is not mentioned in these studies, which means the claim goes beyond what the available research demonstrates. The overall message is correct, but the figure cannot be derived from it. → How dangerous is a fatty liver (hepatic steatosis)?
✗ Does not hold up
“About 50% of people with a fatty liver have a normal or slim build.”
Siggy Clavien (Entrepreneur with a background in plant medicine and viticulture, founder of liver health brand Delivrance) · Dave Asprey, September 2026 · watch the episode ↗︎ · stated with confidence
Large systematic reviews summarising many studies at once show that around 40% of people with a fatty liver are not obese, and about 19% have a normal weight (slim). The claim of "about 50%" therefore deviates from what the research finds: most studies arrive at figures clearly below 50%. One review even states that only 10 to 20% of people with a fatty liver have a normal weight. The overall message is correct, though: you absolutely do not need to be overweight to develop a fatty liver. → How dangerous is a fatty liver (hepatic steatosis)?
Partly
“Thin people with fatty liver disease have a 200 to 300 percent higher mortality rate than overweight people with fatty liver disease.”
Siggy Clavien (Entrepreneur with a background in plant medicine and viticulture, founder of liver health brand Delivrance) · Dave Asprey, September 2026 · watch the episode ↗︎ · stated with confidence
Several human studies confirm that thin people with fatty liver disease die more often than overweight people with fatty liver disease, but the exact size of that difference varies considerably between studies. One large review study, which pooled the results of multiple studies, found a 34% higher risk of dying from any cause and a more than twice as high risk of dying from liver disease. Another study found a 2.5 times higher risk of dying from any cause, and yet another calculated a nearly 3.6 times higher risk of dying from liver disease specifically. A smaller Japanese study found no clear difference in mortality. The claim that mortality is 200 to 300 percent higher does not match well with what most studies show: the increases found for dying from any cause are usually below 200 percent, while dying from liver disease specifically does fall within that range in some studies. The claim is therefore too categorical and too broadly worded. → How dangerous is a fatty liver (hepatic steatosis)?
✗ Does not hold up
“Starting bioidentical hormone replacement therapy at the onset of the perimenopause reduces the risk of premature death in women.”
Siggy Clavien (Entrepreneur with a background in plant medicine and viticulture, founder of liver health brand Delivrance) · Dave Asprey, September 2026 · watch the episode ↗︎ · stated with confidence
The claim makes two specific assertions at once: that bio-identical hormone therapy is clearly superior to conventional therapy, and that starting early reduces all-cause mortality. What the research actually shows is more nuanced: hormone therapy has well-established benefits for symptoms and bone health, and those who start early have the most favourable balance of benefits and risks, but a demonstrable reduction in all-cause mortality has not been proven. For bio-identical hormone therapy specifically, no completed trials with relevant outcomes are available, so there is no evidence that this variant outperforms other forms in this regard.

Chloe Melas

American entertainment journalist and author

✗ Does not hold up
“In scientific studies, inulin causes the same intestinal inflammation as gluten.”
Chloe Melas (American entertainment journalist and author) · Dave Asprey, November 2026 · watch the episode ↗︎ · stated with confidence
Research into inulin shows the exact opposite of what the claim states. Multiple studies, including a review of studies in humans and animals, describe inulin as a prebiotic that can reduce intestinal inflammation and strengthen the intestinal barrier. No comparison with gluten was made in these studies, and inulin is not described as causing the same type of intestinal inflammation as gluten. High doses of inulin can cause gastrointestinal complaints in some people, but that is a different effect from the immune-system inflammatory response associated with gluten in sensitive individuals.
Partly
“A twice-daily combination of an H1 blocker (Claritin) and an H2 blocker (Pepcid AC) calms mast cells in conditions such as long COVID.”
Chloe Melas (American entertainment journalist and author) · Dave Asprey, November 2026 · watch the episode ↗︎ · stated with confidence
H1 and H2 blockers are indeed described in the medical literature as a way to suppress mast cell activity and the effects of histamine in conditions such as mast cell activation syndrome. A case report of one patient with post-viral symptoms shows improvement after taking loratadine (Claritin) and famotidine (Pepcid AC) twice daily, but this is a single case with no comparison group. For long COVID specifically, the evidence is weak: a review article concludes that antihistamines are considered a possible treatment but that there is too little direct evidence to make recommendations, and an observational study suggests a protective effect of antihistamines in long COVID, without examining the specific combination of loratadine and famotidine twice daily. The claim that this specific combination "calms" mast cells in long COVID goes beyond what the available human research demonstrates.
Partly
“Intestinal parasites such as tapeworm eggs and whipworm eggs reduce intestinal inflammation.”
Chloe Melas (American entertainment journalist and author) · Dave Asprey, November 2026 · watch the episode ↗︎ · stated with confidence
Research in mice does indeed show that certain parasitic worms and their eggs can reduce intestinal inflammation, but in humans the evidence is still very limited. A Cochrane review found only two small studies with a total of 90 participants and concluded that there is insufficient evidence to draw firm conclusions about either efficacy or safety. The claim suggests that the effect applies broadly to tapeworms and whipworms in humans, whereas medical research in humans focuses almost exclusively on whipworm eggs (Trichuris suis) and the results remain uncertain. This effect has not yet been demonstrated in humans for tapeworms.
Too early
“EGCG blocks the NLRP3 protein complex and thereby inhibits inflammatory cascades.”
Chloe Melas (American entertainment journalist and author) · Dave Asprey, November 2026 · watch the episode ↗︎ · repeated in November 2026 · stated with confidence
Several studies show that EGCG inhibits the activity of the NLRP3 protein complex and thereby suppresses inflammatory signals. This has been demonstrated in experiments with mice, including in the context of gout, diabetes, lung damage and liver inflammation, as well as in computer simulations of binding to the NLRP3 complex. All of this research has been conducted in mice or in the laboratory, not in humans. The clinical trial registry shows that studies involving humans have barely been completed and contain no published results. The claim makes no distinction between animals and humans, and that distinction is precisely what matters here: whether this effect also occurs in humans has not yet been demonstrated.
✗ Does not hold up
“Anyone who wants to stay healthy in the long run should eat 1 gram of animal protein per pound of body weight every day.”
Chloe Melas (American entertainment journalist and author) · Dave Asprey, November 2026 · watch the episode ↗︎ · stated with confidence
This claim has two problems. First, it uses pounds, whereas the research works with kilograms: 1 gram per pound amounts to over 2 grams per kilogram, well above the evidence-based upper limit of 1.6 grams per kilogram for muscle maintenance. Second, the claim states that it must specifically be animal protein, but population studies consistently show that plant protein performs better on long-term health outcomes. The word "daily" also lacks an important nuance: how much protein is beneficial depends partly on life stage, as a high protein intake in middle age is associated with increased mortality, whereas older adults actually benefit from adequate protein.

Tim Cook

Physician with 30 years of experience in longevity medicine

Partly
“A treatment in which the body's own immune cells and stem cells are influenced by stem cells from umbilical cord blood leads to hair growth in people with alopecia totalis after 6 to 12 months.”
Tim Cook (Physician with 30 years of experience in longevity medicine) · Dave Asprey, October 2026 · watch the episode ↗︎ · stated with confidence
A small case series of three patients has been published in which stem cells from umbilical cord blood were used for forms of hair loss, including one case of complete hair loss over the entire body. In those patients, hair growth began after a few months, which broadly confirms the stated period of 6 to 12 months. At the same time, review studies describe stem cell therapy as promising but still at an early stage, with further research needed into its long-term safety and efficacy. The claim that the therapy works specifically in cases of total scalp hair loss by simultaneously influencing both the immune system and stem cells goes beyond what these limited case descriptions demonstrate: this mechanism of action has not been confirmed in controlled research in humans, and moreover the three reported cases do not all involve the same form of hair loss.
Too early
“Substantially raising follistatin levels causes you to build more muscle and bone and lowers your biological age.”
Tim Cook (Physician with 30 years of experience in longevity medicine) · Dave Asprey, October 2026 · watch the episode ↗︎ · repeated in October 2026 · stated with confidence
Research in mice shows that raising follistatin does indeed increase muscle and bone mass. However, all of this evidence comes from animal studies: the studies use mice, including older animals. Whether this effect also occurs in humans has not yet been demonstrated. The same applies to the claim that biological age decreases: this has not yet been tested in humans. Clinical trials in humans have been registered, but have not yet produced any published results. → How do you raise your follistatin levels for more muscle and bone building?
✗ Does not hold up
“Raising klotho levels inhibits chronic kidney disease and increases both libido and IQ.”
Tim Cook (Physician with 30 years of experience in longevity medicine) · Dave Asprey, October 2026 · watch the episode ↗︎ · stated with confidence
The role of klotho in chronic kidney disease is biologically plausible and trials in humans are under way, but none of these has yet produced published results. A proven inhibitory effect on kidney disease through raising klotho levels has therefore not been established. The claim that klotho would increase libido or IQ goes even further: those claims do not appear in the available research. For libido, there are proven options such as transdermal testosterone and mindfulness therapy, but klotho plays no demonstrated role in these.
Partly
“Fat around the organs is the most important metabolic factor behind chronic diseases such as diabetes, cancer and cardiovascular disease.”
Tim Cook (Physician with 30 years of experience in longevity medicine) · Dave Asprey, October 2026 · watch the episode ↗︎ · stated with confidence
Visceral fat around the organs disrupts metabolism in several ways simultaneously; that is well supported by the research. The step to "most important metabolic factor" goes further than the evidence justifies: muscle mass, chronic inflammation and other factors each play a substantial role as well. Moreover, the link with cancer is less directly established than that with diabetes and cardiovascular disease, so lumping the three diseases together overstates the certainty.

Dr. Michael Leon

Emeritus professor of neurobiology and behavior at the University of California, Irvine (UC Irvine)

Partly
“A chronically blocked nose causes memory loss and increases the risk of Alzheimer's disease.”
Dr. Michael Leon (Emeritus professor of neurobiology and behavior at the University of California, Irvine (UC Irvine)) · Dave Asprey, September 2026 · watch the episode ↗︎ · stated with confidence
Research in humans shows that persistent nasal complaints such as a chronically blocked nose, inflamed sinuses and chronic nasal inflammation are associated with mild cognitive difficulties such as trouble concentrating, and that these complaints improve after treatment. Long-term studies following large groups of people over extended periods have also found a modest increase in the risk of dementia in general. However, the link with Alzheimer's disease specifically is not clear-cut: some large studies find an elevated risk, others find no association, and the quality of the evidence is rated as low to very low. The claim that a chronically blocked nose "causes" memory loss goes beyond what the studies show, as they demonstrate an association but cannot prove that the nasal complaints are actually the cause.
Partly
“The sense of smell in middle age can reliably and accurately predict all-cause mortality.”
Dr. Michael Leon (Emeritus professor of neurobiology and behavior at the University of California, Irvine (UC Irvine)) · Dave Asprey, September 2026 · watch the episode ↗︎ · stated with confidence
Several large studies that followed large groups of people over extended periods of time, and two studies that summarised and compared the findings of earlier research, show that a poorer sense of smell is associated with a higher risk of death. This association persists even after accounting for other health factors. The direction of the claim is therefore correct. However, the claim goes beyond what the research demonstrates: the studies concern almost exclusively older adults (generally aged 57 and above), not middle-aged people. In the 40 to 64 age group, one study found no clear association at all. Moreover, the researchers themselves describe it as a signal or indicator of physical decline, not as a reliable and accurate tool for predicting the future. The associations found are statistically real, but not very strong, and the studies also differed considerably in design.
Partly
“Even after recovering from a mild COVID-19 infection, long-lasting damage to the olfactory system occurs and memory loss develops.”
Dr. Michael Leon (Emeritus professor of neurobiology and behavior at the University of California, Irvine (UC Irvine)) · Dave Asprey, September 2026 · watch the episode ↗︎ · stated with confidence
Research shows that smell problems after a mild COVID-19 infection can indeed persist for a long time: in some patients they are still measurably detectable after more than a month, and sometimes many months later, and there is also evidence of changes in the olfactory region of the brain. That loss of smell is accompanied by cognitive complaints such as brain fog is also reported in the studies, but this is not the same as demonstrated memory loss. The claim that there is "memory loss" goes beyond what the research shows: the studies measure cognitive complaints and symptoms, but not specific memory loss as an established diagnosis. Moreover, the long-term effect does not apply to all people after mild COVID-19, but only to some of them.
Partly
“Olfactory enrichment relieves depressive symptoms, even in people with Alzheimer's disease.”
Dr. Michael Leon (Emeritus professor of neurobiology and behavior at the University of California, Irvine (UC Irvine)) · Dave Asprey, September 2026 · watch the episode ↗︎ · stated with confidence
Research shows that stimulation through smell and through multiple senses simultaneously can reduce depressive symptoms in people with dementia, but the evidence is still limited and does not paint a consistent picture. A review study and summaries of multiple studies in people with dementia found positive effects on mood, but a small randomised controlled study in people with mild to moderate dementia found no clear difference on the depression scale between the groups. The claim that olfactory stimulation specifically relieves depressive symptoms in Alzheimer's disease goes beyond what the research demonstrably shows: the studies often concern broader groups of people with dementia and combine smell with other sensory stimuli or treatments, so the purely isolated effect of smell remains unclear.

Phil Cowley

Pharmacist

Partly
“In carriers of a specific MTHFR gene variant, a supplement containing phosphorylated vitamin B2 lowers blood pressure by about 6 points”
Phil Cowley (Pharmacist) · Dave Asprey, November 2026 · watch the episode ↗︎ · stated with confidence
Multiple randomised studies show that vitamin B2 specifically lowers blood pressure in carriers of the MTHFR 677TT genotype. The reduction in systolic blood pressure found across studies ranges from 5 to 13 mmHg, not consistently "about 6 points" as the claim states. Moreover, the studies used regular riboflavin (1.6 mg per day), not a chemically modified form; whether such variants have the same effect has not yet been studied in humans. A recent scientific review pooling four studies rated the overall evidence as very uncertain and noted that most studies are susceptible to bias in their outcomes.
✓ Holds up
“High doses of regular pyridoxine (vitamin B6) can cause neuropathy and numbness in the hands and feet”
Phil Cowley (Pharmacist) · Dave Asprey, November 2026 · watch the episode ↗︎ · repeated in October 2026 · stated with confidence
Multiple studies in humans, including a review bringing together all available research and a large study of 172 women, confirm that high doses of pyridoxine can lead to sensory disturbances, numbness and other nerve-related complaints, particularly in the arms and legs. A review study concludes that the harmful effect of vitamin B6 on the nervous system at high intake is well supported by scientific evidence. A case report of an individual patient, a 92-year-old woman, and Dutch reports of adverse effects also show that this effect occurs in practice. There is some nuance: sensitivity varies from person to person and even lower doses have sometimes been linked to complaints, but the core of the claim is firmly supported. → Can too much vitamin B6 cause neuropathy or numbness?
Partly
“Myo-inositol in a ratio of 40 to 1 helps women with PCOS reduce excessive hair growth on the chin”
Phil Cowley (Pharmacist) · Dave Asprey, November 2026 · watch the episode ↗︎ · stated with confidence
Research in women with PCOS shows that inositol (including the 40:1 ratio of myo-inositol and D-chiro-inositol) can help lower androgen levels and reduce hyperandrogenism in general, including excessive hair growth. However, one systematic review explicitly concludes that metformin outperforms inositol on hirsutism (excessive hair growth) and that the evidence for inositol in this area is limited and uncertain. The study that specifically examined the 40:1 ratio found no clinical changes in hair growth after twelve weeks, as that period proved too short for such changes to occur. The claim therefore holds for androgen levels in the blood, but the direct effect on visible hair growth on the chin has not yet been well demonstrated in humans.
Partly
“Statins lower CoQ10 levels in the body, which can lead to brain fog and muscle cramps.”
Phil Cowley (Pharmacist) · Dave Asprey, November 2026 · watch the episode ↗︎ · repeated in November 2026 · stated with confidence
Statins do indeed lower CoQ10 levels in the blood, and this is acknowledged in the literature on statin use as a reason to discuss CoQ10 with your doctor. The link with muscle problems is the most frequently cited in this context. However, brain fog as a result of statin-related CoQ10 deficiency goes a step further than what the available research firmly establishes. Muscle cramps and brain fog can be side effects of statins, but whether lowered CoQ10 is the causal link has not been proven.

JP Sears

American comedian and content creator

Partly
“Sufficient testosterone in the body raises dopamine levels.”
JP Sears (American comedian and content creator) · Dave Asprey, November 2026 · watch the episode ↗︎ · repeated in September 2026 · stated with confidence
Research shows that testosterone and related steroids influence the functioning of the dopamine system in the brain. Animal studies indicate that testosterone acts on the mesolimbic dopamine system, and review studies describe how androgens can influence dopamine signalling in brain regions involved in reward and motivation. However, the claim goes further than what the evidence supports: the studies describe an interaction between testosterone and dopamine, but do not unambiguously show that normal ('sufficient') testosterone levels raise dopamine levels in humans. Much of the research has been conducted in animal models or concerns supraphysiological doses (anabolic steroid abuse), not the normal amount of testosterone in the human body.
✗ Does not hold up
“Testosterone replacement therapy reduces the risk of cancer and cardiovascular disease and extends lifespan”
JP Sears (American comedian and content creator) · Dave Asprey, November 2026 · watch the episode ↗︎ · stated with confidence
Research shows positive effects in men with a proven deficiency on sexual function and mood, and the feared risks of prostate cancer and serious heart problems are less well supported than was long assumed. But that is very different from saying that testosterone therapy actively reduces the risk of cancer and cardiovascular disease or extends lifespan: there is no evidence for that broad protective and life-extending effect. There is even a possible increased risk of irregular heart rhythm and bone fractures. The claim therefore goes considerably further than what research has shown so far.
Partly
“A cold-water bath makes the body produce more cold-shock proteins”
JP Sears (American comedian and content creator) · Dave Asprey, November 2026 · watch the episode ↗︎ · stated with confidence
Research shows that cold does indeed stimulate the production of special proteins that the body produces at low temperatures, but this has so far only been demonstrated in mice and in cells in the laboratory, not in people taking a cold-water bath. The studies also show that the temperature at which these proteins are produced most strongly (around 32–34°C) is much lower than average body temperature, but it has not yet been investigated in humans whether a cold-water bath provides enough cooling to trigger this effect. The direction of the claim is therefore consistent with what is known from animal and laboratory research, but the step to the everyday cold-water bath in humans has not yet been made in the available research. → Can cold showers make your cells healthier?

Dr. Michael Breus

Clinical psychologist and sleep specialist

Partly
“Sleeping naked with socks on improves sleep because warm feet open blood vessels and dissipate body heat more quickly.”
Dr. Michael Breus (Clinical psychologist and sleep specialist) · Dave Asprey, October 2026 · watch the episode ↗︎ · stated with caution
The mechanism is correct: warm feet dilate the blood vessels in the skin, allowing heat to escape from the body more quickly and lowering the core temperature, which promotes falling asleep. This fits with the broader picture that a slight drop in body temperature is needed to fall asleep well. However, the evidence for socks specifically is exploratory and comes from small studies involving young healthy men, so the claim does not apply to everyone without qualification. Whether sleeping naked is the decisive factor in this is not firmly established by the research.
Partly
“To fall asleep, the body must lower its temperature, heart rate, and anxiety level.”
Dr. Michael Breus (Clinical psychologist and sleep specialist) · Dave Asprey, October 2026 · watch the episode ↗︎ · stated with confidence
A lower body temperature does indeed play a role in falling asleep: research shows that heat disrupts sleep and that a cooler environment helps. Stress and anxiety are also demonstrably linked to sleep, and people who are less anxious fall asleep more easily. However, the research does not identify heart rate as a separate condition that one must consciously lower, and the claim gives the impression that all three factors are equally well supported and equally necessary, which goes further than the evidence shows.
Partly
“Eating at fixed times helps regulate the body's circadian rhythm”
Dr. Michael Breus (Clinical psychologist and sleep specialist) · Dave Asprey, October 2026 · watch the episode ↗︎ · stated with confidence
Research shows that meal timing is linked to your biological clock: eating late disrupts the circadian rhythm and is associated with metabolic problems, while a regular eating pattern with meals earlier in the day has a beneficial effect on blood sugar and hormone balance. The claim that fixed mealtimes actively help regulate the circadian rhythm is therefore broadly correct in its direction, but the available evidence is predominantly based on associations rather than demonstrated cause and effect, and comes mainly from short-term studies.

Dr. Karan Rajan

British surgeon, former NHS doctor and author on health and medicine

Partly
“Drinking black coffee daily helps reverse liver fibrosis and slows the progression of chronic liver disease.”
Dr. Karan Rajan (British surgeon, former NHS doctor and author on health and medicine) · Dave Asprey, September 2026 · watch the episode ↗︎ · stated with confidence
That coffee is beneficial for the liver is well established: large population studies consistently point to a lower risk of liver conditions and liver cancer in regular coffee drinkers. However, the claim goes beyond what the evidence supports. The word "reverse" implies that existing liver fibrosis is rolled back, and that has not been demonstrated in the available research. Moreover, the associations found are just that: associations, not proof of cause and effect.
Partly
“Eating enough soluble fibre prevents excreted oestrogen from being reabsorbed in the large intestine.”
Dr. Karan Rajan (British surgeon, former NHS doctor and author on health and medicine) · Dave Asprey, September 2026 · watch the episode ↗︎ · stated with confidence
Research in women shows that a high-fibre diet is associated with more oestrogen in the stool and lower oestrogen levels in the blood, suggesting that fibre can reduce the reabsorption of oestrogen from the gut. This effect is attributed to the gut microbiome, which can release oestrogen in the intestine so that it is reabsorbed; fibre appears to inhibit this process. However, the claim goes beyond the evidence on two points: the studies do not always distinguish between soluble fibre and fibre in general, and they consist largely of observational studies and early-stage research in which the underlying mechanism has not yet been definitively established. One study in male rats confirmed the effect on faecal excretion, but that is animal research.

Amitay Eshel & Anastasia Zhukova

Founders of skincare company Young Goose, specializing in cellular aging and skin biology

✗ Does not hold up
“Long-term frequent use of exfoliating acids damages the skin barrier later in life and results in thinner skin.”
Amitay Eshel & Anastasia Zhukova (Founders of skincare company Young Goose, specializing in cellular aging and skin biology) · Dave Asprey, October 2026 · watch the episode ↗︎ · stated with confidence
Research in humans and animals shows precisely the opposite of what the claim asserts. Studies with glycolic acid in humans showed that the skin barrier remained intact: transepidermal water loss did not change and the barrier structures were not damaged. In guinea pigs, the epidermal thickness doubled after the use of glycolic acid, and in mice the barrier function even improved slightly. The claim that long-term use damages the skin barrier and makes the skin thinner is therefore not supported by the available research and contradicts what those studies actually found.
Partly
“Methylene blue stimulates collagen production and increases collagen thickness in human skin.”
Amitay Eshel & Anastasia Zhukova (Founders of skincare company Young Goose, specializing in cellular aging and skin biology) · Dave Asprey, October 2026 · watch the episode ↗︎ · stated with confidence
Research shows that methylene blue in a three-dimensional skin model made of human tissue causes skin cells to be more active in producing collagen, making the skin thicker as a result. However, this is laboratory research using a reconstructed skin model, not a study in living humans. A second study shows that methylene blue in cultured skin cells can prevent collagen production from being suppressed, but that is a very different situation from actively stimulating collagen production in healthy human skin. The claim presents the finding as an established effect in humans, whereas the evidence is still limited to laboratory and cell studies.

Kiran Krishnan

microbiologist and scientific researcher

✗ Does not hold up
“Prolonged and frequent endurance cardio increases the risk of bowel cancer because too little blood reaches the intestines during exercise.”
Kiran Krishnan (microbiologist and scientific researcher) · Dave Asprey, October 2026 · watch the episode ↗︎ · stated with confidence
Research actually shows the opposite: regular moderate-intensity physical activity reduces the risk of bowel cancer, and multiple reviews confirm that this is one of the best-supported protective effects of exercise on the gastrointestinal tract. It is true that during intense and prolonged exercise blood flow to the intestines temporarily decreases and that this can cause intestinal ischaemia, but that is an acute, transient condition with no link to an increased risk of bowel cancer. The claim therefore reverses the evidence: reduced blood flow is indeed a recognised mechanism behind complaints in intense athletes, but it does not lead to bowel cancer and regular physical activity actually protects against it.
Too early
“Serratol, a substance from the frankincense tree Boswellia, stimulates cartilage cells to rebuild damaged cartilage.”
Kiran Krishnan (microbiologist and scientific researcher) · Dave Asprey, October 2026 · watch the episode ↗︎ · stated with confidence
Research shows that a Boswellia serrata extract (of which serratol is a component) can stimulate cartilage cells to repair damaged tissue and inhibit inflammatory processes. This has been demonstrated in laboratory studies using cells and in animal experiments with rats, but not yet in research involving humans. Moreover, the studies always concern a complete extract of Boswellia, not serratol as an isolated substance. Whether serratol itself, independently of the other components of the extract, is responsible for cartilage repair has not yet been tested in humans.

Sarah Kennedy

former veterinarian and founder of Calocurb

Partly
“During a 24-hour water fast, Calocurb reduces the increase in hunger by 100 percent and food cravings by 120 percent in women.”
Sarah Kennedy (former veterinarian and founder of Calocurb) · Dave Asprey, October 2026 · watch the episode ↗︎ · stated with confidence
A study of thirty women shows that Amarasate® (the extract in Calocurb) clearly and demonstrably reduces hunger and the desire to eat during a 24-hour water fast compared to a placebo. The direction of the claim is therefore correct. However, the precise percentages of 100% and 120% do not appear in the study's abstract: it only states that the effect was measurably and reliably demonstrated, without providing specific percentages for the group of women. The claim therefore goes beyond what the published research concretely supports. → Does Calocurb help with hunger and binge eating in women?

Jim Kwik

Memory trainer, author and expert in brain training and speed reading

✓ Holds up
“Exercise stimulates the production of BDNF (Brain-Derived Neurotrophic Factor), which promotes neuroplasticity and neurogenesis.”
Jim Kwik (Memory trainer, author and expert in brain training and speed reading) · Dave Asprey, August 2026 · watch the episode ↗︎ · repeated in September 2026 · stated with confidence
That exercise raises BDNF has been measured in humans and is one of the best-supported links between physical activity and the brain. The step towards neurogenesis is less firmly established, because whether adult humans generate new brain cells remains a matter of debate.

From the episodes, no speaker named

Partly
“Sleeping just one night in a room with ordinary indoor lighting already causes a measurably increased insulin resistance the following morning.”
Dave Asprey, September 2026 · watch the episode ↗︎ · stated with confidence
Light in the bedroom at night is indeed associated with poorer blood sugar regulation, and there are early indications that a dark sleeping environment has a beneficial effect on blood sugar response in the morning. However, the evidence for this is not yet conclusive, and the claim that ordinary indoor lighting causes a measurably increased insulin resistance after just one night goes beyond what the research has established so far. The available studies show an association, not a proven causal response after a single night.
Partly
“Ketones stimulate the production of the brain growth factor BDNF.”
Dave Asprey, November 2026 · watch the episode ↗︎ · stated with confidence
Research in mice shows that beta-hydroxybutyrate (BHB), a so-called ketone body that the body produces when carbohydrate intake is low, can promote the production of BDNF. It does so by blocking certain proteins that normally suppress BDNF production. A mouse study in an enriched environment also found this link, and several scientific review articles describe this as a plausible mechanism. However, a study in people with type 2 diabetes, in which participants received ketone supplements, found no effect whatsoever on BDNF in the blood or in the cerebral cortex. Moreover, the same study also found no change in mice. The claim holds for part of the available evidence, but the effect has not yet been demonstrated in humans and the research findings contradict each other.
✓ Holds up
“The ketone beta-hydroxybutyrate inhibits the NLRP3 inflammasome in cells and in mice.”
Dave Asprey, November 2026 · watch the episode ↗︎ · stated with confidence
Several studies show that beta-hydroxybutyrate (BHB) inhibits the NLRP3 inflammasome, both in cells and in mice and rats. One study demonstrates the effect in human white blood cells, but the core of the evidence rests on animal and cell research. The claim explicitly states 'in cells and in mice', and that picture corresponds well with what the studies show: in multiple cell types and in animal research using mice, BHB inhibits the activity of this inflammatory mechanism in conditions including gout, Alzheimer's disease and heart failure.
Partly
“C8 MCT oil raises blood ketone levels more than three times as much as coconut oil.”
Dave Asprey, November 2026 · watch the episode ↗︎ · stated with confidence
Research in healthy people consistently shows that C8 MCT oil raises ketone levels considerably more than coconut oil. One study with 15 older adults found that coconut oil barely raised ketone levels above the control oil, whereas C8 did, but the measured values do not amount to a factor of three. Another study with seven young, healthy participants confirms that C8 produces the strongest ketone response of all variants tested, but likewise gives no figure of 'more than three times as much'. The direction of the claim is therefore correct, but the specific figure of three times more is not supported by the research.
Partly
“Overweight men who eat medium-chain fatty acids (MCT) instead of olive oil lose 66 percent more fat.”
Dave Asprey, November 2026 · watch the episode ↗︎ · stated with confidence
Research in humans does indeed show that MCT oil leads to greater fat loss than olive oil or other long-chain fats. The 2008 study with registration number 18326600 examined both overweight men and women and found a clearly lower final body weight with MCT use, but the study compared men and women together and does not report a figure of 66 percent more fat loss. The figure of 66 percent does appear in the study by Tsuji et al. with registration number 11694608, where in people with elevated body weight the reduction in fat mass in the MCT group (-3.86 kg) compared with the group using long-chain fats (-2.75 kg) roughly reflects that difference, but that study compared MCT with long-chain fats in general, not specifically with olive oil, and included both men and women. The claim is therefore well supported in its main conclusion, but the specific figure and the restriction to men go beyond what the individual studies clearly demonstrate.
Partly
“A cholesterol level between 200 and 240 is associated with the lowest risk of death, while a level below 200 increases the risk of dying.”
Dave Asprey, November 2026 · watch the episode ↗︎ · stated with confidence
A large Korean study that followed more than 12 million adults for many years does indeed show a U-shaped relationship between total cholesterol levels and the risk of death. The lowest risk of death was found at a cholesterol level between 210 and 249 mg/dL, which aligns with the core of the claim. However, in younger women the most favourable range was lower, namely below 200, meaning the ideal level is not the same for everyone. Moreover, this concerns an association that researchers observed without changing anything: people with a low cholesterol level may die sooner because they are already ill, not because that low cholesterol is inherently dangerous. A large study in which researchers randomly assigned people to groups and actively lowered LDL cholesterol in some of them actually shows that this reduces the risk of death, which tells a different story from the idea that a lower level would itself be more harmful. → What is a healthy cholesterol level and when should I be concerned?
Partly
“Ketamine makes the brain more neuroplastic.”
Dave Asprey, October 2026 · watch the episode ↗︎ · stated with confidence
Several review studies show that ketamine stimulates the formation of new connections between brain cells, thereby making the brain more adaptable. This effect is well documented in animal research, where ketamine demonstrably promotes the growth of connections in the cerebral cortex. In humans, the evidence is encouraging but less complete: studies with patients show that ketamine has rapid antidepressant effects that go hand in hand with changes in brain connectivity, but directly measuring structural changes in those connections in humans is still limited. The claim is therefore essentially correct, but it implies more certainty than the research in humans currently provides.
Partly
“Ketamine shuts down the default mode network in the brain.”
Dave Asprey, October 2026 · watch the episode ↗︎ · stated with confidence
Several human studies show that ketamine weakens the connections within the default mode network (DMN), but the network is not simply "shut down". Researchers found, for example, that in healthy volunteers ketamine reduced the connection between the medial prefrontal cortex and the rest of the network, while connections in other parts of the brain actually increased. A review study that carefully pooled all available research on patients with depression also describes primarily reductions in DMN connectivity, not a complete shutdown. The claim implies an all-or-nothing effect, whereas the research shows that ketamine partially and selectively disrupts the network, with some connections decreasing while others change or remain intact.
Partly
“The amino acid leucine in proteins is the most important factor that activates mTOR.”
Dave Asprey, October 2026 · watch the episode ↗︎ · repeated in October 2026 · stated with confidence
Leucine does indeed play a role in mTOR activation, and eating less protein lowers mTOR activity, which is consistent with the claim. However, research points to multiple factors that influence mTOR, such as fasting, calorie intake and the energy status of the cell. Identifying leucine as the "most important factor" goes beyond what the available evidence supports.
Partly
“Rapamycin slows wound healing.”
Dave Asprey, October 2026 · watch the episode ↗︎ · stated with confidence
Several studies in people taking sirolimus (rapamycin) after an organ transplant show that impaired wound healing is a well-known side effect, and medical review articles confirm this pattern. Animal studies support this as well: rapamycin slowed wound healing in animals with poorly vascularised wounds, while another animal study found that a related drug targeting the same pathway in the body could actually promote wound healing in diabetic mice. The claim therefore holds for people taking rapamycin to prevent transplant rejection, but the picture is not clear-cut for all situations: the effect depends on the context, such as a healthy wound versus a wound in someone with diabetes or a wound with insufficient oxygen supply.
Partly
“Eating butter raises the level of protective HDL cholesterol in the blood”
Dave Asprey, November 2026 · watch the episode ↗︎ · stated with confidence
Human research does indeed show that butter can raise good cholesterol, but the picture is more nuanced than the claim suggests. One study found a rise in good cholesterol compared to a regular diet, but not compared to olive oil. Another study found that coconut oil raised good cholesterol considerably more than butter did, and a third study found no changes in cholesterol levels due to butter in people who were overweight and had a disturbed metabolism. This is therefore not a straightforward protective effect: butter simultaneously raises bad cholesterol as well, which is considered a risk factor, and whether the rise in good cholesterol actually proves protective depends on what you compare butter with and in which group.
Partly
“The fatty acid conjugated linoleic acid (CLA) is associated with a reduction in body fat”
Dave Asprey, November 2026 · watch the episode ↗︎ · stated with confidence
Several review studies summarising the results of well-designed trials in adults show that taking CLA as a supplement is associated with a small reduction in fat mass and body weight. The direction of the claim is therefore correct. However, the researchers themselves are cautious: the effects are small and in practice they by no means always make a meaningful difference in people. Moreover, an analysis that includes only the best studies shows no clear reduction in fat mass. Animal studies show stronger effects than human studies, and there are indications that the effect depends on how long someone takes the supplement, what dose is used, and which group is involved (for example, people who are overweight).
Partly
“Vitamin K2 transports calcium to the bones and ensures that calcium stays out of the arterial walls.”
Dave Asprey, November 2026 · watch the episode ↗︎ · repeated in November 2026 · stated with confidence
Vitamin K2 activates proteins that direct calcium to bone tissue and slow down calcification of the arteries, and that mechanism is broadly correct. Research shows that K2 improves bone density and slows the build-up of calcium deposits in the coronary arteries. However, the claim suggests a precise and fully proven transport mechanism, whereas the observed effects are modest and apply primarily to people with bone problems or existing arterial calcification, not necessarily to everyone.
✗ Does not hold up
“There is no meaningful difference in the risk of cardiovascular disease between the intake of saturated and unsaturated fat.”
Dave Asprey, November 2026 · watch the episode ↗︎ · stated with confidence
Several large review studies in humans show that the claim is incorrect. Two Cochrane reviews involving tens of thousands of participants find that reducing saturated fat lowers the risk of cardiovascular disease by 17 to 21% compared to a normal diet. A third review confirms this pattern and adds that the effect is strongest in people who already have an elevated risk, and that replacing saturated fat with polyunsaturated fat provides additional benefit. Only one review study from 2015, based on observational data without researcher intervention, found no clearly demonstrable association for saturated fat on its own. However, that study did not examine what happens when saturated fat is replaced by unsaturated fat. The picture from studies in which researchers directly adjusted participants' diets is therefore clear enough to contradict the claim.
Partly
“Metformin inhibits muscle growth and hypertrophy in response to strength training in healthy adults.”
Dave Asprey, September 2026 · watch the episode ↗︎ · repeated in November 2026 · stated with confidence
A carefully designed scientific study, the so-called MASTERS trial, in which adults aged 65 and over were randomly assigned to two groups that each received a different treatment without knowing which one they were taking, produced the following findings. Participants who took metformin gained significantly less muscle mass and muscle density during strength training than participants who received a placebo. The claim is therefore correct for older adults, but the evidence explicitly applies only to that age group and has not yet been studied in younger, healthy adults. Moreover, a closer analysis of the same study shows that concurrent use of cholesterol-lowering drugs may cancel out the inhibitory effect of metformin on muscle growth, meaning that the outcome depends on other medication a person is taking. The claim is therefore too broadly formulated, as it makes no distinction by age group and includes no caveat for this type of drug interaction.
Partly
“Increasing the gut bacterium Akkermansia muciniphila improves insulin sensitivity by 28% over three months.”
Dave Asprey, September 2026 · watch the episode ↗︎ · repeated in November 2026 · stated with confidence
A small exploratory study in humans, in which neither the participants nor the researchers knew who was receiving which treatment, does indeed show an improvement in insulin sensitivity of +28.62% after three months of taking pasteurised Akkermansia muciniphila, compared with a placebo. That figure is therefore correct. However, the claim omits two important conditions: the effect was specific to pasteurised bacteria (live bacteria did not produce this effect), and the study was small-scale, involving 32 participants who were already insulin-resistant and overweight. Moreover, a later study in people with type 2 diabetes shows that the effect depends strongly on how much Akkermansia a person already has in their gut: in people who already had high levels of this bacterium, barely any improvement was measured. The claim gives the impression that this is a general and established effect, whereas the evidence so far is limited to specific groups and circumstances.
Partly
“Exercise activates AMPK, which inhibits the functioning of mTOR.”
Dave Asprey, October 2026 · watch the episode ↗︎ · repeated in November 2026 · stated with confidence
Exercise does indeed activate AMPK, and that mechanism is well established in the research, with high exercise intensity producing the strongest effect. However, AMPK does not have a simple on-off relationship with mTOR: activating AMPK can inhibit mTOR, but the claim presents this as a direct and inevitable step, whereas research has not yet fully worked out that chain in humans. The most practical and well-supported ways to lower mTOR are fasting and protein restriction, not exercise specifically.
Partly
“Continuous use of rapamycin can disrupt metabolism and lead to insulin resistance and blood sugar problems.”
Dave Asprey, October 2026 · watch the episode ↗︎ · stated with caution
The fact that rapamycin can disrupt blood sugar regulation is a well-documented risk: disruption of blood sugar regulation and blood sugar disorders are described as known side effects in multiple sources. The claim emphasises continuous use as the decisive factor, but the available research does not draw that distinction sharply: even short-term use in patients is already associated with these risks. Whether long-term use in healthy people taking it preventively actually leads to clinically relevant insulin resistance has not yet been adequately studied in humans.
Partly
“Rapamycin extends the lifespan of mice by about 25%, even when treatment is started at an advanced age.”
Dave Asprey, October 2026 · watch the episode ↗︎ · stated with confidence
The research clearly shows that rapamycin can extend the lifespan of mice. However, the figure of about 25% and the specific claim that this also works when started late cannot be firmly established on the basis of the available evidence. Moreover, the claim overlooks an important nuance: what works in mice does not automatically translate to humans, and an effect on lifespan has not yet been demonstrated in healthy people.
Partly
“People with a normal weight but with abdominal fat have an almost twice as high risk of dying compared to people with a normal weight and no belly fat.”
Dave Asprey, September 2026 · watch the episode ↗︎ · stated with confidence
Large observational studies consistently show that abdominal fat strongly increases the risk of premature death, even in people with a normal weight and no other measurable metabolic problems. The direction of the claim is therefore correct. However, the specific figure of 'an almost twice as high risk of dying' cannot be firmly established based on the available research, and moreover these are observational associations in which cause and effect have not been fully proven.
Newsletter

Stay in the loop

Every Thursday, the most important longevity research in your inbox, focused on what you follow.